Small Molecule
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
183
NCT03760666
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 20, 2018
Completion: Feb 9, 2021
NCT04425252
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
Start: Aug 19, 2020
Completion: Jan 12, 2021
NCT04575038
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
Phase: Phase 2
Start: Nov 19, 2020
Completion: Apr 28, 2021
NCT05166876
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
Start: Feb 1, 2022
Completion: Jun 4, 2022
Loading map...